A listing agreement is a contract that allows a real estate broker to perform specific marketing and selling tasks for a property. It does not transfer title to the broker and establishes the broker as an independent contractor. The correct answer to the question is A: It allows a broker to complete a specific task.
The exclusive right to sell listing agreement is the most common type of agreement in real estate. Under this arrangement, the broker is given exclusive rights to market the property for a set period.
A real estate listing agreement – also known as a seller's agent agreement – is a contract between a property owner and a real estate broker. It permits the broker to sell the home on the seller's terms, locating an appropriate buyer. The property owner pays the brokerage a commission for acting as the listing agent.
Expert-Verified Answer. A written listing agreement between a seller and a broker is a bilateral contract because both parties make promises to each other. The seller agrees to sell the property, while the broker agrees to find a buyer.
A listing agreement is “a legally binding contract that creates an agency relationship authorizing a broker to serve as the agent for a principal in a real estate transaction.” In other words, a listing agreement is an employment contract between a client and a broker that spells out what the broker is responsible for ...
A listing agreement is a contract between a property owner and a real estate brokerage that authorizes the broker to represent the seller and act as their agent in the sale of the property.
A listing agreement is between the parties that own a property and the agents or brokers who will find a buyer for it. Typically, a real estate listing agreement involves the property owner and a real estate agent. The property owner, or seller, grants the agent the right to market and sell the property.
Known under a variety of names, a common element of these product listing agreements (PLAs) is the negotiation of confidential prices that are typically achieved through rebates that may or may not be tied to drug expenditures, utilization patterns or health outcomes.